Evidence map›Paper›PMID 17848512›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2007

Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1.

Paul A Ramsland, Natasha Willoughby, Halina M Trist, William Farrugia, P Mark Hogarth, John D Fraser, Bruce D Wines

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed.

  1. Review
  2. Article
  3. Scabies.Nature reviews. Disease primers · 2024
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. 3D Structures of IgA, IgM, and Components.International journal of molecular sciences · 2021
    Review
  11. Article
  12. Review
  13. A VFrontiers in plant science · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. IgA: Structure, Function, and Developability.Antibodies (Basel, Switzerland) · 2019
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paul A RamslandThe Inflammatory Disease and Structural Immunology Laboratories, The Burnet Institute, Austin Hospital, Studley Road, Heidelberg, Victoria 3084, Australia.
Natasha Willoughby
Halina M Trist
William Farrugia
P Mark Hogarth
John D Fraser
Bruce D Wines

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infection by Staphylococcus aureus can result in severe conditions such as septicemia, toxic shock, pneumonia, and endocarditis with antibiotic resistance and persistent nasal carriage in normal individuals being key drivers of the medical impact of this virulent pathogen. In both virulent infection and nasal colonization, S. aureus encounters the host immune system and produces a wide array of factors that frustrate host immunity. One in particular, the prototypical staphylococcal superantigen-like protein SSL7, potently binds IgA and C5, thereby inhibiting immune responses dependent on these major immune mediators. We report here the three-dimensional structure of the complex of SSL7 with Fc of human IgA1 at 3.2 A resolution. Two SSL7 molecules interact with the Fc (one per heavy chain) primarily at the junction between the Calpha2 and Calpha3 domains. The binding site on each IgA chain is extensive, with SSL7 shielding most of the lateral surface of the Calpha3 domain. However, the SSL7 molecules are positioned such that they should allow binding to secretory IgA. The key IgA residues interacting with SSL7 are also bound by the leukocyte IgA receptor, FcalphaRI (CD89), thereby explaining how SSL7 potently inhibits IgA-dependent cellular effector functions mediated by FcalphaRI, such as phagocytosis, degranulation, and respiratory burst. Thus, the ability of S. aureus to subvert IgA-mediated immunity is likely to facilitate survival in mucosal environments such as the nasal passage and may contribute to systemic infections.

Indexed as

Antigens, CDBacterial ProteinsBinding Sites, AntibodyCells, CulturedCrystallography, X-RayGenes, BacterialHumansImmunoglobulin AModels, MolecularMutagenesisProtein ConformationReceptors, FcRecombinant Fusion ProteinsStaphylococcus aureusSuperantigensAntigens, CDBacterial ProteinsFc(alpha) receptorImmunoglobulin AReceptors, FcRecombinant Fusion ProteinsSuperantigens

Identifiers

PMID17848512
PMCPMC1986611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.